Description: Beximco Pharmaceuticals Limited (BPL) is engaged in the manufacturing and marketing of generic pharmaceuticals formulation products, including intravenous fluids and active pharmaceutical ingredients (APIs). The Company also provides contract manufacturing services. The Company produces approximately 300 generic medicines, which are available in over 500 different presentations and the portfolio encompasses various key therapeutic categories, including antibiotics, analgesics, anti-diabetic, respiratory, cardiovascular, central nervous system, dermatology and gastrointestinal. Its product categories also include anti-infectives, musculoskeletal, oncology, respiratory, skin care, vitamins and minerals supplement, and others. The Company's products include Acifix, Femzole, Q-Rash, Tamona, Taverin, Tobasol, IcyKool Cream, Intracef, Gastalfet, Iprasol, Calorate, Gentosep and others. BPL's products are sold in domestic and international markets.
Home Page: www.beximcopharma.com
BXP Technical Analysis
19 Dhanmondi R/A
Dhaka,
1205
Bangladesh
Phone:
880 2 5861 1001
Officers
| Name | Title |
|---|---|
| Mr. S. M. Rabbur Reza | Chief Operating Officer |
| Mr. Jamal Ahmed Choudhury | Director of Accounts & Finance |
| Mr. Rizvi Ul Kabir | Director of Marketing |
| Mr. M. A. Arshad Bhuiyan | General Manager of Human Resources |
| Mr. Zakaria Seraj Chowdhury | Head of Distribution Services & Director of International Marketing |
| Mr. Mohammad Asad Ullah FCS | Company Secretary & Executive Director |
Exchange: LSE
Country: UK : United Kingdom
Currency: Pence sterling (p)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Biotechnology |
| GIC Sub-Industry: | Biotechnology |
| Forward PE: | 4.583 |
|---|---|
| Trailing PE: | 4.0556 |
| Price-to-Book MRQ: | 0.5071 |
| Price-to-Sales TTM: | 0.0056 |
| IPO Date: | |
| Fiscal Year End: | June |
| Full Time Employees: | 1122 |